New Study Confirms MarginProbe® Demonstrates a 51% Reduction in Re-Excision Procedures

By DAY Vision | February 29, 2016

[vc_row][vc_column][vc_column_text] Ductal invasive cancer patients saw 89.8 percent reduction in re-excisions in a 322 patient prospective study Paoli, PA, Feb. 29, 2016 – New research lead by Professor Jens-Uwe Blohmer, director of the department of gynecology and the breast center of the Charité, Charité – Universitätsmedizin Berlin, demonstrates that proper use of MarginProbe, the first…

Read More